706
Views
32
CrossRef citations to date
0
Altmetric
Articles

Shared care or nurse consultations as an alternative to rheumatologist follow-up for rheumatoid arthritis (RA) outpatients with stable low disease-activity RA: cost-effectiveness based on a 2-year randomized trial

, , &
Pages 13-21 | Accepted 25 May 2014, Published online: 07 Nov 2014

References

  • Report for the specialty: rheumatology. Copenhagen: National Board of Health, 2008. http://sundhedsstyrelsen.dk/da/sundhed/planlaegning-og-beredskab/specialeplanlaegning/specialeplan-2010/~/media/18AEB358CC5241B890AE2BBBE556A164.ashx.
  • Hill J, Thorpe R, Bird H. Outcomes for patients with RA: a rheumatology nurse practitioner clinic compared to standard outpatient care. Musculoskeletal Care 2003;1:5–20.
  • Tijhuis GJ, Zwinderman AH, Hazes JM, Van Den Hout WB, Breedveld FC, Vliet Vlieland TP. A randomized comparison of care provided by a clinical nurse specialist, an inpatient team, and a day patient team in rheumatoid arthritis. Arthritis Rheum 2002;47:525–31.
  • Hewlett S, Mitchell K, Haynes J, Paine T, Korendowych E, Kirwan JR. Patient-initiated hospital follow-up for rheumatoid arthritis. Rheumatology 2000;39:990–7.
  • Hewlett S, Kirwan J, Pollock J, Mitchell K, Hehir M, Blair PS, et al. Patient initiated outpatient follow up in rheumatoid arthritis: six year randomised controlled trial. Br Med J 2005;330:171.
  • Kirwan JR, Mitchell K, Hewlett S, Hehir M, Pollock J, Memel D, et al. Clinical and psychological outcome from a randomized controlled trial of patient-initiated direct-access hospital follow-up for rheumatoid arthritis extended to 4 years. Rheumatology 2003;42:422–6.
  • Symmons D, Tricker K, Harrison M, Roberts C, Davis M, Dawes P, et al. Patients with stable long-standing rheumatoid arthritis continue to deteriorate despite intensified treatment with traditional disease modifying anti-rheumatic drugs – results of the British Rheumatoid Outcome Study Group randomized controlled clinical trial. Rheumatology 2006;45:558–65.
  • Ndosi M, Lewis M, Hale C, Quinn H, Ryan S, Emery P, et al. The outcome and cost-effectiveness of nurse-led care in people with rheumatoid arthritis: a multicentre randomised controlled trial. Ann Rheum Dis. Published online: 27 August 2013. doi: 10.1136/annrheumdis-2013-203403.
  • Ndosi M, Lewis M, Hale C, Quinn H, Ryan S, Emery P, et al. A randomised, controlled study of outcome and cost effectiveness for RA patients attending nurse-led rheumatology clinics: study protocol of an ongoing nationwide multi-centre study. Int J Nurs Stud 2011;48:995–1001.
  • Primdahl J, Sørensen J, Horn HC, Petersen R, Horslev-Petersen K. Shared care or nursing consultations as an alternative to rheumatologist follow-up for rheumatoid arthritis outpatients with low disease activity – patient outcomes from a 2-year, randomised controlled trial. Ann Rheum Dis 2014;73:357–64.
  • Primdahl J, Wagner L, Holst R, Horslev-Petersen K, AMBRA Study Group. The impact on self-efficacy of different types of follow-up care and disease status in patients with rheumatoid arthritis – a randomized trial. Patient Educ Couns 2012;88:121–8.
  • Primdahl J, Wagner L, Horslev-Petersen K. Being an outpatient with rheumatoid arthritis – a focus group study on patients’ self-efficacy and experiences from participation in a short course and one of three different outpatient settings. Scand J Caring Sci 2011;25:394–403.
  • Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315–24.
  • Prevoo ML, van ‘t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44–8.
  • Fries JF, Spitz PW, Young DY. The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. J Rheumatol 1982;9:789–93.
  • Kind P, Brooks R, Rabin R, editors. EQ-5D concepts and methods: a developmental history. Dordrecht: Springer, ed2005 2005.
  • Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. AnnMed. 2001;33(5):337–43.
  • Salaffi F, Cimmino MA, Leardini G, Gasparini S, Grassi W. Disease activity assessment of rheumatoid arthritis in daily practice: validity, internal consistency, reliability and congruency of the Disease Activity Score including 28 joints (DAS28) compared with the Clinical Disease Activity Index (CDAI). ClinExpRheumatol. 2009;27(4):552–9.
  • Fransen J, van Riel PL. The Disease Activity Score and the EULAR response criteria. Rheumatic Diseases Clinics of North America. 2009;35(4):745–57, vii-viii.
  • Bruce B, Fries JF. The Health Assessment Questionnaire (HAQ). ClinExpRheumatol. 2005;23(5 Suppl 39):S14–S8.
  • Janssen MF, Birnie E, Bonsel GJ. Quantification of the level descriptors for the standard EQ-5D three-level system and a five-level version according to two methods. Qual Life Res 2008;17:463–73.
  • Wittrup-Jensen KU, Lauridsen J, Gudex C, Pedersen KM. Generation of a Danish TTO value set for EQ-5D health states. Scand J Public Health 2009;37:459–66.
  • van Hout B, Janssen MF, Feng YS, Kohlmann T, Busschbach J, Golicki D, et al. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health 2012; 15:708–15.
  • Linde L, Sorensen J, Ostergaard M, Horslev-Petersen K, Hetland ML. Health-related quality of life: validity, reliability, and responsiveness of SF-36, 15D, EQ-5D [corrected] RAQoL, and HAQ in patients with rheumatoid arthritis. J Rheumatol 2008;35:1528–37.
  • Manca A, Hawkins N, Sculpher MJ. Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ 2005;14:487–96.
  • Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 2011;20: 1727–36.
  • Hetland ML. DANBIO – powerful research database and electronic patient record. Rheumatology 2011;50:69–77.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.